DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $391,015 | -1.2% | 1,565 | -1.3% | 0.13% | -1.5% |
Q1 2024 | $395,806 | -9.5% | 1,585 | -16.1% | 0.13% | -17.3% |
Q4 2023 | $437,233 | -6.0% | 1,890 | +0.8% | 0.16% | -16.1% |
Q3 2023 | $465,188 | +3.4% | 1,875 | 0.0% | 0.19% | +80.4% |
Q2 2023 | $450,000 | -16.0% | 1,875 | -11.8% | 0.11% | -15.1% |
Q1 2023 | $535,585 | -19.8% | 2,125 | -15.5% | 0.13% | -21.7% |
Q4 2022 | $667,531 | -3.5% | 2,515 | -6.2% | 0.16% | -10.1% |
Q3 2022 | $692,000 | +1.9% | 2,680 | 0.0% | 0.18% | +6.5% |
Q2 2022 | $679,000 | -13.9% | 2,680 | -0.4% | 0.17% | -1.8% |
Q1 2022 | $789,000 | -10.8% | 2,690 | 0.0% | 0.17% | -8.6% |
Q4 2021 | $885,000 | +8.1% | 2,690 | 0.0% | 0.19% | +2.2% |
Q3 2021 | $819,000 | +13.4% | 2,690 | 0.0% | 0.18% | +14.4% |
Q2 2021 | $722,000 | +16.1% | 2,690 | -2.7% | 0.16% | +10.3% |
Q1 2021 | $622,000 | -10.1% | 2,765 | -11.2% | 0.14% | -15.7% |
Q4 2020 | $692,000 | +27.4% | 3,115 | +23.6% | 0.17% | +11.0% |
Q3 2020 | $543,000 | +39.2% | 2,520 | +14.3% | 0.16% | +30.3% |
Q2 2020 | $390,000 | – | 2,205 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |